| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092510 Novel 2, 3 - benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 05/13/2004 | US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists |
| 05/13/2004 | US20040092493 Method for ameliorating male erectile dysfunction |
| 05/13/2004 | US20040092488 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 05/13/2004 | US20040092486 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 05/13/2004 | US20040092477 Compositions for the treatment and prevention of arterial thrombosis and use of an inhibitor of factor Xa alone and/or in combination with an anti-platelet aggregation agent |
| 05/13/2004 | US20040092473 Method for nucleic acid transfection of cells |
| 05/13/2004 | US20040092455 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
| 05/13/2004 | US20040092447 Uses of kappa-conotoxin PVIIA |
| 05/13/2004 | US20040092444 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 05/13/2004 | US20040092434 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 05/13/2004 | US20040092429 Cardiovascular disorders; antiarrhythmia agents; controlling phosphorylation of cells, tissues |
| 05/13/2004 | US20040091895 Human sprouty-4 polypeptide |
| 05/13/2004 | US20040091534 Once-daily administrations characterised by a high degree of absorption using pellets comprising a powder mixture of drug, acid/base excipients and diluent surrounded by a multilayer membrane of water soluble and insoluble polymers to control |
| 05/13/2004 | US20040091497 Use as a biological target for the treatment and diagnosis of schizophrenia and bipolar disorder for example; drug screening; transgenic non-human animals for use as animal models |
| 05/13/2004 | US20040091496 Vaccine |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091425 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same |
| 05/13/2004 | US20040091423 Methods for identifying asymptomatic patients who have a likelihood of benefiting from administration of an estrogen activity modulator for risk reduction or therapeutic treatment of breast cancer, methods for reducing risk or |
| 05/13/2004 | DE10250687A1 7H-Dibenzo(b,g)(1,5)dioxocin-5-on-Derivate und ihre Verwendung 7H-dibenzo (b, g) (1.5) dioxocin-5-one derivatives and their use |
| 05/13/2004 | CA2503962A1 Compounds, methods and devices for inhibiting neoproliferative changes in blood vessel walls |
| 05/13/2004 | CA2503881A1 7h-dibenzo[b,g][1,5]dioxocin-5-one derivatives and use thereof |
| 05/13/2004 | CA2503624A1 Use of a nitric oxide donor to prevent desensitization of g-protein coupled receptors |
| 05/12/2004 | EP1418293A1 System for the construction of water retaining walls, such as swimming pool walls, with prefabricated panels |
| 05/12/2004 | EP1418234A1 Human monoclonal antibodies against oxidized ldl receptor and medicinal use thereof |
| 05/12/2004 | EP1418177A1 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions |
| 05/12/2004 | EP1418176A1 Pyrazole derivates, their preparation and their use in drugs |
| 05/12/2004 | EP1417976A1 Remedy for glaucoma comprising as the active ingredient compound having pi3 kinase inhibitory effect |
| 05/12/2004 | EP1417971A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 05/12/2004 | EP1417963A1 Highly purified EPA and derivatives for psychiatric and neurological disorders |
| 05/12/2004 | EP1417351A2 Antisense modulation of apolipoprotein(a) expression |
| 05/12/2004 | EP1417350A2 Antisense modulation of hormone-sensitive lipase expression |
| 05/12/2004 | EP1417349A2 Novel molecular target for neurotoxicity |
| 05/12/2004 | EP1417307A2 Oligonucleotide compositions and their use to induce apoptosis |
| 05/12/2004 | EP1417304A2 Method and composition for inhibiting heparanase activity |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417189A1 Acylaminothiazole derivatives, their preparation and therapeutic use |
| 05/12/2004 | EP1417187A1 Aryl substituted thiazolidinones and the use thereof |
| 05/12/2004 | EP1417182A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417179A1 Polymorph salt of a pyridazinone derivative for the treatment of arrhythmia |
| 05/12/2004 | EP1417173A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/12/2004 | EP1417172A1 Process for the preparation of amorphous form of torsemide |
| 05/12/2004 | EP1417169A2 Selective estrogen receptor modulators |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416974A1 Gas microsphere liposome composites |
| 05/12/2004 | EP1416962A2 Method of improving cognitive function |
| 05/12/2004 | EP1416961A1 Composition and method for the treatment of disease |
| 05/12/2004 | EP1416954A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 05/12/2004 | EP1416952A1 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases |
| 05/12/2004 | EP1416950A1 Artichoke leaf extracts |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/12/2004 | EP1416940A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/12/2004 | EP1416937A1 Prophylactic and therapeutic use of hydroxysteroids |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416932A1 New dipeptidyl peptidase iv inhibitors and their uses for lowering blood pressure levels |
| 05/12/2004 | EP1416931A1 Inhibitors of polyq-aggregation |
| 05/12/2004 | EP1416927A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 05/12/2004 | EP1416925A2 Uses of targeted oxidative therapeutic formulation in arteriosclerosis |
| 05/12/2004 | EP1416885A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 05/12/2004 | EP1416884A2 Delivery of therapeutic capable agents |
| 05/12/2004 | EP1416795A1 Compositions and methods for treatment of mitochondrial diseases |
| 05/12/2004 | EP1311485A4 Processes for preparing cilostazol |
| 05/12/2004 | EP1292303B1 A stable pharmaceutical formulation comprising torsemide modification ii |
| 05/12/2004 | EP1265903B1 Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 05/12/2004 | EP1237856B1 New tri-substituted phenyl derivatives and analogues |
| 05/12/2004 | EP1226267B1 Process for producing a product containing antihypertensive tripeptides |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1146863B1 Lyophilisates with improved reconstitutibility |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1119254A4 Novel treatment for stroke management |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | EP1112070B1 Novel substituted triazole compounds |
| 05/12/2004 | EP1102745B1 A process for the preparation of zofenopril calcium salt |
| 05/12/2004 | EP1063235B1 Benzofurylpyrone derivatives |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | EP1007556B1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | EP0862444B1 Treatment of dilated cardiomyopathy by removal of autoantibodies |
| 05/12/2004 | EP0833911B1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof |
| 05/12/2004 | EP0792156B1 Medicaments for the prevention or treatment of vascular hemorrhaging |
| 05/12/2004 | CN1496407A Flavonoid compound and process for producing the same |
| 05/12/2004 | CN1496366A Triazolopyridines as anti-inflammatory agents |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1496361A 苯基衍生物3 Phenyl derivative 3 |
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
| 05/12/2004 | CN1496271A Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 05/12/2004 | CN1496265A Medicine for fighting against sexual dysfunction |
| 05/12/2004 | CN1496264A 4-fluoro-N-indan-2-Y1 benzamide and its use as pharmaceutical |
| 05/12/2004 | CN1496261A Remedies and/or preventives for diabetic ischemic heart diseases |